Policy decisions by federal and commercial payers have expanded coverage for the TIF 2.0 procedure in 2018, extending access to effective long-term control of acid reflux symptoms REDMOND, Wash. – Federal and commercial payer plans responsible for over 100 million...
New EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes. REDMOND, Wash. – EsophyX® Z+ device offers expanded endoscope compatibility and joins EndoGastric Solutions’® portfolio of specialized...
Expanded Medicare coverage and update to facility reimbursement increases patient access to non-surgical alternative for long-term control of acid reflux symptoms REDMOND, Wash. (November 14, 2017) – Medicare beneficiaries in 23 additional states have been...
Effective alternative for long-term control of acid reflux symptoms will now be available to over 60% of Medicare patients REDMOND, Wash. – Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral...
